- 3.3Impact Factor
- 6.8CiteScore
- 14 daysTime to First Decision
Special Issues
Pathogens publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Piroplasms and Tick-Borne Pathogens: Transmission, Surveillance, and One Health Perspectives
Deadline: 31 May 2026
Human Papillomavirus Vaccination: Progress and Challenges in Global Immunization Strategies
Deadline: 31 May 2026
One Health Surveillance of Sand-Fly and Leishmania Transmission
Deadline: 31 May 2026
Surveillance and Molecular Epidemiology of Viral Encephalitis Pathogens
Deadline: 31 May 2026
Therapeutic Strategies for Mycobacterium Infections Novel Drug Development
Deadline: 31 May 2026
Current Research on Influenza Viruses: Evolution, Immunity, and Countermeasures
Deadline: 31 May 2026
Airborne Transmission of Pathogens
Deadline: 30 May 2026
Current Challenges in Veterinary Virology
Deadline: 30 May 2026
Current Advances in Pathogen Diagnosis and Discovery Methods
Deadline: 30 May 2026
Emerging Antibiotic Resistance in Nosocomial Pathogens: Current Trends and Future Directions
Deadline: 30 May 2026
New Insights into Viral Infections of Domestic Animals
Deadline: 30 May 2026
Advances in Virus-Host Interactions, Viral Pathogenicity and Antiviral Drug Development
Deadline: 20 May 2026
of 67

